GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCC2 | 53 | Hepatic Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.0106 | 28554132
|
ABCB1 | 40 | Hepatic Cancer | Carcinoma | NA | SP assay followed by IHC staining | 0.32 | 0.0604 | 26592953
|
ABCG2 | 74 | Hepatic Cancer | Carcinoma | NA | SP assay followed by IHC staining | 0.32 | 0.1739 | 26592953
|
AFP | 317 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.0021 | 23104270
|
KIT | 6342 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.018 | 23104270
|
NANOG | 20857 | Hepatic Cancer | NA | NA | FACs | 0.28 | 0.5461 | 26942873
|
NANOG | 20857 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.5461 | 23104270
|
NCAM1 | 7656 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.0074 | 23104270
|
POU5F1 | 9221 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.6448 | 23104270
|
SOX2 | 11195 | Hepatic Cancer | NA | NA | SP assay followed by qRT-PCR and SFA | 0.28 | 0.5695 | 23104270
|
SOX2 | 11195 | Hepatic Cancer | NA | NA | FACs | 0.28 | 0.5695 | 26942873
|
ABCB5 | 46 | Hepatic Cancer | NA | NA | FACs | 0.2 | 0.0085 | 26942873
|
ANPEP | 500 | Hepatic Cancer | Carcinoma | NA | FACs | 0.2 | 0.0117 | 22969999
|
ANPEP | 500 | Hepatic Cancer | NA | NA | SP assay followed by FACs | 0.2 | 0.0117 | 23104270
|
CTNNB1 | 2514 | Hepatic Cancer | NA | NA | FACs | 0.2 | 0.0647 | 26942873
|
EPCAM | 11529 | Hepatic Cancer | NA | NA | FACs | 0.2 | 0.211 | 26942873
|
EPCAM | 11529 | Hepatic Cancer | NA | NA | SP assay followed by FACs | 0.2 | 0.211 | 23104270
|
GRN | 4601 | Hepatic Cancer | NA | NA | FACs and CFA followed by SFA and Tumorigenicity assay | 0.2 | 0.0032 | 26942873
|
PROM1 | 9454 | Hepatic Cancer | NA | NA | FACs | 0.2 | 0.7582 | 26942873
|
PROM1 | 9454 | Hepatic Cancer | NA | NA | SP assay followed by FACs | 0.2 | 0.7582 | 23104270
|
THY1 | 11801 | Hepatic Cancer | NA | NA | SP assay followed by FACs | 0.2 | 0.0371 | 23104270
|